To further explore the molecular mechanism of PD on GC, combined with the above network pharmacological analysis, we analyzed the key pathways involved in PD treating GC via Western blotting: the PI3K–AKT, TNF, and IL-17 pathways. The gene discussed is AKT1; the disease is gastric cancer.